ONLINE DATABASE SEARCH - OI-LS-361-MEMO
1. 59396 OI-LS-361; SCIFINDER-OI-11/7/2006
Synthesis and in vitro anti-tubercular activity of a series of N'-(disubstitutedbenzoyl)isoniazid derivatives
Neves, Ivan Jr, Lourenco, Maria CS, de Miranda, Guilherme de BP, Vasconcelos, Thatyana RA, Pais, Karla C, de A, Jose dos P Jr, Wardell, Solange MSV, Wardell, James L, and de Souza, Marcus VN
Letters in Drug Design & Discovery 2006. 3(6): 424-428
2. 59397 OI-LS-361; PUBMED-OI-11/13/2006
Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis
Seidel, M, Alderwick, LJ, Sahm, H, Besra, GS, and Eggeling, L
Glycobiology 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17088267&dopt=abstract
3. 59398 OI-LS-361; SCIFINDER-OI-11/7/2006
Activity of 6-O-substituted macrolides against Mycobacterium tuberculosis
Zhu, Zhaohai, Petukhova, Valentina Z, Pan, Dahua, Wan, Baojie, Wang, Yuehong, Krasnykh, Olga, Yu, Gengli, Schellinger, Kate, and Franzblau, Scott G
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006 2006.: MEDI-349
4. 59399 OI-LS-361; PUBMED-OI-11/13/2006
Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth
Long, MC, Allan, PW, Luo, MZ, Liu, MC, Sartorelli, AC, and Parker, WB
J Antimicrob Chemother 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17085766&dopt=abstract
5. 59400 OI-LS-361; SCIFINDER-OI-11/7/2006
Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity
Mueller, Daniela, Krick, Anja, Kehraus, Stefan, Mehner, Christian, Hart, Mark, Kuepper, Frithjof C, Saxena, Krishna, Prinz, Heino, Schwalbe, Harald, Janning, Petra, Waldmann, Herbert, and Koenig, Gabriele M
Journal of Medicinal Chemistry 2006. 49(16): 4871-4878
6. 59401 OI-LS-361; PUBMED-OI-11/13/2006
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion
Harris, JE, Green, JA, Elkington, PT, and Friedland, JS
J Leukoc Biol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17079649&dopt=abstract
7. 59402 OI-LS-361; PUBMED-OI-11/13/2006
SMALL INTERFERING RNA TARGETED TO HEPATITIS C VIRUS 5'NONTRANSLATED REGION EXERTS POTENT ANTIVIRAL EFFECT
Kanda, T, Steele, R, Ray, R, and Ray, RB
J Virol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17079316&dopt=abstract
8. 59403 OI-LS-361; SCIFINDER-OI-11/7/2006
Novel antituberculosis compounds, hirsutellones A, C, and C
Isaka, Masahiko, Hywel-Jones, Nigel L, Somrithipol, Sayanh, Kirtikara, Kanyawim, Palittapongarnpim, Prasit, and Thebtaranonth, Yodhathai
PATENT: US 2006122252 ISSUE DATE: 20060608
APPLICATION: 2005-23378 PP: 21 pp.
ASSIGNEE: (National Center for Genetic Engineering, Thailand and Biotechnology, National Science & Technology Development Agency
9. 59404 OI-LS-361; PUBMED-OI-11/13/2006
Multidrug-resistant tuberculosis management in resource-limited settings
Nathanson, E, Lambregts-van, Weezenbeek C, Rich, ML, Gupta, R, Bayona, J, Blondal, K, Caminero, JA, Cegielski, JP, Danilovits, M, Espinal, MA, Hollo, V, Jaramillo, E, Leimane, V, Mitnick, CD, Mukherjee, JS, Nunn, P, Pasechnikov, A, Tupasi, T, Wells, C, and Raviglione, MC
Emerg Infect Dis 2006. 12(9): 1389-97
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17073088&dopt=abstract
10. 59405 OI-LS-361; PUBMED-OI-11/13/2006
Synthesis and biological evaluation of 4-methylideneisoxazolidin-5-ones - A new class of highly cytotoxic alpha-methylidene-gamma-lactones
Rozalski, M, Krajewska, U, Panczyk, M, Mirowski, M, Rozalska, B, Wasek, T, and Janecki, T
Eur J Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17069934&dopt=abstract
11. 59406 OI-LS-361; SCIFINDER-OI-11/7/2006
The 5-Deoxy-5-methylthio-xylofuranose Residue in Mycobacterial Lipoarabinomannan. Absolute Stereochemistry, Linkage Position, Conformation, and Immunomodulatory Activity
Joe, Maju, Sun, Daniel, Taha, Hashem, Completo, Gladys C, Croudace, Joanne E, Lammas, David A, Besra, Gurdyal S, and Lowary, Todd L
Journal of the American Chemical Society 2006. 128(15): 5059-5072
12. 59407 OI-LS-361; PUBMED-OI-11/13/2006
In Vitro Inhibition of Toxoplasma gondii by Four New Derivatives of Artemisinin
Jones-Brando, L, D'Angelo, J, Posner, GH, and Yolken, R
Antimicrob Agents Chemother 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17060514&dopt=abstract
13. 59408 OI-LS-361; SCIFINDER-OI-11/7/2006
Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives
Guezel, Oezlen and Salman, Aydin
Bioorganic & Medicinal Chemistry 2006. 14(23): 7804-7815
14. 59409 OI-LS-361; SCIFINDER-OI-11/7/2006
<04 Article Title>
Kenyon, James and Trischman, Jacqueline
<10 Journal Title> 2006.(<24 Issue ID>): <25 Page(s)>
15. 59410 OI-LS-361; SCIFINDER-OI-11/7/2006
Synthesis and antituberculosis activity of 2-(aryl/alkylamino)-5-(4-aminophenyl)-1,3,4-thiadiazoles and their Schiff bases
Solak, Nilufer and Rollas, Sevim
ARKIVOC (Gainesville, FL, United States) 2006.(12): 173-181
16. 59411 OI-LS-361; PUBMED-OI-11/13/2006
Editorial: The treatment of multi-drug resistant tuberculosis - a return to the pre-antibiotic era?
Olle-Goig, JE
Trop Med Int Health 2006. 11(11): 1625-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17054741&dopt=abstract
17. 59412 OI-LS-361; SCIFINDER-OI-11/7/2006
Structure-activity relationships at the 5-position of thiolactomycin: An intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli
Kim, Pilho, Zhang, Yong-Mei, Shenoy, Gautham, Nguyen, Quynh-Anh, Boshoff, Helena I, Manjunatha, Ujjini H, Goodwin, Michael B, Lonsdale, John, Price, Allen C, Miller, Darcie J, Duncan, Ken, White, Stephen W, Rock, Charles O, Barry, Clifton E III, and Dowd, Cynthia S
Journal of Medicinal Chemistry 2006. 49(1): 159-171
18. 59413 OI-LS-361; PUBMED-OI-11/13/2006
Cost of treatment for multidrug-resistant tuberculosis in South Korea
Kang, YA, Choi, YJ, Cho, YJ, Lee, SM, Yoo, CG, Kim, YW, Han, SK, Shim, YS, and Yim, JJ
Respirology 2006. 11(6): 793-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17052310&dopt=abstract
19. 59414 OI-LS-361; PUBMED-OI-11/13/2006
siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations
Konishi, M, Wu, CH, Kaito, M, Hayashi, K, Watanabe, S, Adachi, Y, and Wu, GY
J Viral Hepat 2006. 13(11): 756-61
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17052275&dopt=abstract
20. 59415 OI-LS-361; SCIFINDER-OI-11/7/2006
Design and synthesis of a novel nanomolar inhibitor of Toxoplasma gondii dihydrofolate reductase, its salt form and analogs
Gangjee, Aleem, Lin, Xin, Biondo, Lisa R, and Queener, Sherry F
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006 2006.: MEDI-363
21. 59416 OI-LS-361; PUBMED-OI-11/13/2006
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis
Gao, XF, Wang, L, Liu, GJ, Wen, J, Sun, X, Xie, Y, and Li, YP
Int J Tuberc Lung Dis 2006. 10(10): 1080-90
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17044199&dopt=abstract
22. 59417 OI-LS-361; PUBMED-OI-11/13/2006
Antituberculosis drug resistance in the south of Vietnam: prevalence and trends
Huong, NT, Lan, NT, Cobelens, FG, Duong, BD, Co, NV, Bosman, MC, Kim, SJ, van, Soolingen D, and Borgdorff, MW
J Infect Dis 2006. 194(9): 1226-32
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17041848&dopt=abstract
23. 59418 OI-LS-361; WOS-OI-11/6/2006
What is Cryptosporidium? Reappraising its biology and phylogenetic affinities
Barta, JR and Thompson, RCA
TRENDS IN PARASITOLOGY 2006. 22(10): 463-468, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241254500007
24. 59419 OI-LS-361; SCIFINDER-OI-11/7/2006
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
Tay, ST, Haryanty, TTanty, Ng, KP, Rohani, MY, and Hamimah, H
Mycoses 2006. 49(4): 324-330
25. 59420 OI-LS-361; WOS-OI-11/6/2006
Antiprotozoal and antimicrobial activities of Centaurea species growing in Turkey
Karamenderes, C, Khan, S, Tekwani, BL, Jacob, MR, and Khan, IA
PHARMACEUTICAL BIOLOGY 2006. 44(7): 534-539, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241171700008
26. 59421 OI-LS-361; SCIFINDER-OI-11/7/2006
Preparation of 2-thienylacetylenes as antiviral agents
Wunberg, Tobias, Baumeister, Judith, Gottschling, Dirk, Henninger, Kerstin, Koletzki, Diana, Pernerstorfer, Josef, Urban, Andreas, Birkmann, Alexander, Harrenga, Axel, and Lobell, Mario
PATENT: WO 2006072348 ISSUE DATE: 20060713
APPLICATION: 2005 PP: 83 pp.
ASSIGNEE: (Aicuris Gmbh & Co. KG, Germany
27. 59422 OI-LS-361; WOS-OI-11/6/2006
Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus
Cheng, YJ, Niu, JJ, Zhang, YY, Huang, JW, and Li, QG
JOURNAL OF CLINICAL MICROBIOLOGY 2006. 44(10): 3557-3561, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241138800015
28. 59423 OI-LS-361; WOS-OI-11/6/2006
Evaluation of molecular-beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide Polymorphisms in mixed Mycobacterium tuberculosis DNA extracts
Yesilkaya, H, Meacci, F, Niemann, S, Hillemann, D, Rusch-Gerdes, S, Barer, MR, Andrew, PW, and Oggioni, MR
JOURNAL OF CLINICAL MICROBIOLOGY 2006. 44(10): 3826-3829, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241138800060
29. 59424 OI-LS-361; WOS-OI-11/6/2006
A new antifungal macrolide, eushearilide, isolated from Eupenicillium shearii
Hosoe, T, Fukushima, K, Takizawa, K, Itabashi, T, Kawahara, N, Vidotto, V, and Kawai, KI
JOURNAL OF ANTIBIOTICS 2006. 59(9): 597-600, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241312900008
30. 59425 OI-LS-361; WOS-OI-11/6/2006
Biochemical and functional characterization of triosephosphate isomerase from Mycobacterium tuberculosis H37Rv
Mathur, D, Malik, G, and Garg, LC
FEMS MICROBIOLOGY LETTERS 2006. 263(2): 229-235, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241383100016
31. 59426 OI-LS-361; WOS-OI-11/6/2006
Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14 alpha-demethylase (CYP51) of fungi
Zhu, J, Lu, JG, Zhou, YJ, Li, YW, Cheng, J, and Zheng, CH
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2006. 16(20): 5285-5289, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241344400006
32. 59427 OI-LS-361; WOS-OI-11/13/2006
Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats
Guitard, J, Menotti, J, Desveaux, A, Alimardani, P, Porcher, R, Derouin, F, and Kapel, N
PARASITOLOGY RESEARCH 2006. 99(5): 522-527, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241385100002
33. 59428 OI-LS-361; WOS-OI-11/13/2006
Are second-line drugs necessary to control mulfidrug-resistant tuberculosis?
Nardell, EA and Mitnick, CD
JOURNAL OF INFECTIOUS DISEASES 2006. 194(9): 1194-1196, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241418100002
34. 59429 OI-LS-361; WOS-OI-11/13/2006
Mucoralactone A: An unusual steroid from the liquid culture of Mucor plumbeus
Ata, A, Conci, LJ, and Orhan, I
HETEROCYCLES 2006. 68(10): 2097-+, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241420800008
35. 59430 OI-LS-361; WOS-OI-11/13/2006
Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities
Tomioka, H
CURRENT PHARMACEUTICAL DESIGN 2006. 12(31): 4047-4070, 24
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241488300006
36. 59431 OI-LS-361; WOS-OI-11/13/2006
Bioactive constituents of the root bark of Artocarpus rigidus subsp rigidus
Namdaung, U, Aroonrerk, N, Suksamrarn, S, Danwisetkanjana, K, Saenboonrueng, J, Arjchomphu, W, and Suksamrarn, A
CHEMICAL & PHARMACEUTICAL BULLETIN 2006. 54(10): 1433-1436, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241549300015
37. 59432 OI-LS-361; WOS-OI-11/13/2006
Sulfate metabolism in mycobacteria
Schelle, MW and Bertozzi, CR
CHEMBIOCHEM 2006. 7(10): 1516-1524, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241392400005
38. 59433 OI-LS-361; WOS-OI-11/13/2006
Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents
Zhao, GY, Miller, MJ, Franzblau, S, Wan, BJ, and Mollmann, U
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2006. 16(21): 5534-5537, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241447300011
39. 59434 OI-LS-361; WOS-OI-11/13/2006
Now, later or never? Challenges associated with hepatitis C treatment
McNally, S and Temple-Smith, M
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH 2006. 30(5): 422-427, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241440200006